To determine whether PA and CD36 participated in the metastasis of GC in vivo, peritoneal dissemination assay is performed as peritoneum is the most common metastatic site [19] and the most common site of recurrence which markedly influences GC patients’ survival [38]. The gene discussed is CD36; the disease is gastric cancer.